RE:Question For BearsIf you trusted their numbers, they should have had enough cash to pay the earnout without deferring. They deferred and then issued more high interest debt. Some argued they were issuing debt at a lower interest rate to pay of higher interest debt, but they issued at 9% and the rate is much higher when you take into account Goldmans commission. More insider selling on Friday. The facts only point one way now regardless of how people try to spin it. When half your outstanding shares trade in a day and the stock only moves up 73 cents something seems wrong. This will be a traders stock until the truth is finally revealed.
Lumberfeverlong wrote: Do you have any basis for thinking Q3 will be a bad quarter and miss revised guidance in a substantial way? Do the WoW scripts data over the entire quarter indicate more erosion in their NA drugs? Are you aware of any new competition for any of their leading drugs? It is one thing for longs and bears to speculate, but does anyone have any hard facts that would point in one direction or another?